Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endothelial dysfunction in hypertension.

S Taddei1, A Virdis, L Ghiadoni

  • 1Department of Internal Medicine, University of Pisa, Italy. s.taddei@int.med.unipi.it

Journal of Nephrology
|August 6, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The use of bone-modifying agents in early breast cancer: AIOM Guidelines update and perspectives.

Tumori·2025
Same author

PREDICTIVE BRCA GENETIC TESTING IN ITALIAN PATIENTS WITH BREAST CANCER: A POSITION PAPER OF ITALIAN SCIENTIFIC SOCIETIES [Italian Association of Medical Oncology(AIOM); Italian Association of Radiotherapy and Clinical Oncology (AIRO); Italian National Association of Breast Surgeons (ANISC); Italian Society of Pathological Anatomy and Diagnostic Cytology (SIAPeC-IAP); Italian Society of Surgical Oncology (SICO); Italian Society of Human Genetic (SIGU); Italian Society of General Practice (SIMG); Italian Society of Medical and Interventional Radiology (SIRM)].

Cancer treatment reviews·2025
Same author

ANN uncertainty estimates in assessing fatty liver content from ultrasound data.

Computational and structural biotechnology journal·2024
Same author

Comment on: Semaglutide and cardiovascular outcomes in obesity without diabetes.

Journal of endocrinological investigation·2023
Same author

Possible added value of thyroglobulin antibody (TgAb) testing in the evaluation of thyroidal status of subjects with overweight or obesity.

Journal of endocrinological investigation·2022
Same author

Effect of aging on clinical features and metabolic complications of women with polycystic ovary syndrome.

Journal of endocrinological investigation·2021
Same journal

Correction to: Abdominal arterial calcification profile in kidney transplant candidates: a comparison between patients with autosomal dominant polycystic kidney disease and those with other causes of kidney failure.

Journal of nephrology·2026
Same journal

Lessons for the Clinical Nephrologist. Not to see the forest for the trees: the diagnostic challenge with valproic acid-induced Fanconi-like proximal tubulopathy.

Journal of nephrology·2026
Same journal

Longitudinal trajectories in multidomain frailty among patients with chronic kidney disease.

Journal of nephrology·2026
Same journal

Correction to: Association between primary care physician-nephrologist collaboration and clinical outcomes in patients with stage 5 chronic kidney disease: a JOINT-KD cohort study.

Journal of nephrology·2026
Same journal

Improving eGFR estimation in diabetic populations: insights from real-world data.

Journal of nephrology·2026
Same journal

Barriers delaying treatment in cases at risk of crush syndrome in major disasters: Kahramanmaraş earthquake experience.

Journal of nephrology·2026
See all related articles

Endothelial dysfunction in hypertension involves impaired nitric oxide (NO) pathways, potentially driven by cyclooxygenase activation and oxidative stress. This dysfunction promotes atherosclerosis and thrombosis, suggesting it

Area of Science:

  • Vascular Biology and Medicine
  • Cardiovascular Research
  • Hypertension Pathophysiology

Background:

  • The endothelium regulates vascular tone and structure, primarily via nitric oxide (NO).
  • Endothelial dysfunction, characterized by impaired NO bioavailability, is observed in human hypertension across various circulations.
  • This dysfunction appears to be a primary phenomenon in essential hypertension, detectable early and independent of blood pressure levels.

Purpose of the Study:

  • To investigate the mechanisms underlying endothelial dysfunction in essential hypertension.
  • To explore the role of alternative pathways, such as cyclooxygenase, in altering nitric oxide availability.
  • To elucidate how endothelial dysfunction contributes to atherosclerosis and thrombosis in hypertensive individuals.

Main Methods:

Related Experiment Videos

  • The study focuses on the biochemical pathways involved in endothelial function.
  • It examines the interplay between nitric oxide, cyclooxygenase, and oxidative stress in the context of hypertension.
  • Analysis of endothelial cell function and molecular markers in hypertensive patients and their offspring.

Main Results:

  • Essential hypertension is associated with impaired endothelium-dependent vasodilation.
  • Evidence suggests cyclooxygenase activation contributes to reduced nitric oxide availability via oxidative stress.
  • Endothelial dysfunction is linked to increased risk of atherosclerosis and thrombosis in hypertension.

Conclusions:

  • Endothelial dysfunction is a key feature of essential hypertension, preceding significant blood pressure elevation.
  • Activation of the cyclooxygenase pathway and subsequent oxidative stress may underlie the NO deficiency.
  • A dysfunctional endothelium, due to altered NO pathways, is implicated as a promoter of vascular disease in hypertension.